Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “RHYTHM PHARMACEUTICALS, INC.”

11 pharma patents match "RHYTHM PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 11
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 11 pharmaceutical patents matching "RHYTHM PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

11 results for “RHYTHM PHARMACEUTICALS, INC.” · 30,257 patents in full index Clear search

  1. US 12285460

    Pharmaceutical compositions

    RHYTHM PHARMACEUTICALS, INC. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted

  2. US 12263202

    Method of treating melanocortin-4 receptor pathway-associated disorders

    RHYTHM PHARMACEUTICALS, INC. · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted

  3. US 12077612

    Peptide compositions

    RHYTHM PHARMACEUTICALS, INC. · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted

  4. US 11702448

    Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

    RHYTHM PHARMACEUTICALS, INC. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  5. US 11129869

    Pharmaceutical compositions

    RHYTHM PHARMACEUTICALS, INC. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  6. US 10960046

    Method of treating melanocortin-4 receptor pathway-associated disorders

    RHYTHM PHARMACEUTICALS, INC. · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  7. US 10954268

    Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

    RHYTHM PHARMACEUTICALS, INC. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  8. US 10858399

    Peptide compositions

    RHYTHM PHARMACEUTICALS, INC. · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted

  9. US 10196425

    Peptide compositions

    RHYTHM PHARMACEUTICALS, INC. · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  10. US 10167312

    Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

    RHYTHM PHARMACEUTICALS, INC. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  11. US 9845339

    Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

    RHYTHM PHARMACEUTICALS, INC. · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.